carbostyril has been researched along with Autoimmune Demyelinating Diseases, Central Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, J; Duscha, A; Esser, C; Gold, R; Haghikia, A; Mahmoudjanlou, Y; Massa, MG; Thöne, J | 1 |
1 other study(ies) available for carbostyril and Autoimmune Demyelinating Diseases, Central Nervous System
| Article | Year |
|---|---|
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor.
Topics: Analysis of Variance; Animals; Axons; Brain-Derived Neurotrophic Factor; CD3 Complex; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Gene Expression Regulation; Immunologic Factors; Leukemic Infiltration; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Quinolones; Rats; Receptors, Aryl Hydrocarbon; RNA, Messenger; Spinal Cord; T-Lymphocytes; White Matter | 2016 |